Intuitive Surgical (NASDAQ:ISRG) Stock Gets Price Target Trim from BTIG Research

Intuitive Surgical (NASDAQ:ISRG) had its price objective decreased by BTIG Research from $469.00 to $454.00 in a report published on Monday morning, Marketbeat Ratings reports. BTIG Research currently has a buy rating on the medical equipment provider’s stock.

Several other analysts also recently commented on the stock. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Sunday, September 20th. Raymond James Financial reiterated an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Leerink Partners lowered their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Truist Financial lowered their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Finally, Barclays upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Wednesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical Price Performance

ISRG stock opened at $420.24 on Monday. The company has a fifty day moving average price of $389.39 and a two-hundred day moving average price of $409.80. Intuitive Surgical has a one year low of $328.57 and a one year high of $603.88. The stock has a market cap of $148.46 billion, a price-to-earnings ratio of 50.55, a price-to-earnings-growth ratio of 3.18 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 earnings per share. Research analysts anticipate that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Activity

In other news, Director Amy L. Ladd sold 72 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the transaction, the director directly owned 179 shares in the company, valued at approximately $70,364.90. The trade was a 28.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares of the company’s stock, valued at approximately $330,877.17. This trade represents a 8.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 12,370 shares of company stock valued at $4,891,989. Company insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ISRG. William Allan Corp bought a new position in Intuitive Surgical in the third quarter worth approximately $292,000. Hudock Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $207,000. Fortitude Family Office LLC grew its stake in Intuitive Surgical by 155.2% in the third quarter. Fortitude Family Office LLC now owns 998 shares of the medical equipment provider’s stock valued at $406,000 after acquiring an additional 607 shares during the period. Strategy Asset Managers LLC increased its holdings in shares of Intuitive Surgical by 2.9% during the third quarter. Strategy Asset Managers LLC now owns 3,622 shares of the medical equipment provider’s stock valued at $1,473,000 after acquiring an additional 103 shares in the last quarter. Finally, Union Savings Bank increased its holdings in shares of Intuitive Surgical by 28.6% during the third quarter. Union Savings Bank now owns 1,419 shares of the medical equipment provider’s stock valued at $577,000 after acquiring an additional 316 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: ISRG shares have gained nearly 12% over the past month, supported by increasing adoption of the da Vinci 5 surgical system and continued growth in the Ion robotic platform. ISRG Gains Nearly 12% in a Month
• Positive Sentiment: Zacks upgraded Intuitive Surgical to Rank #2, or Buy, citing improving earnings prospects. UBS also reiterated a Buy rating and maintained a $500 price target, pointing to the company’s long-term robotic-surgery growth runway. ISRG Upgraded to Buy UBS Reiterates Buy Rating
• Positive Sentiment: Intuitive Surgical is pursuing growth beyond surgery after submitting a next-generation robotic endoscope to the FDA for gastrointestinal procedures. Approval could create a sizable new market, although timing and regulatory clearance remain uncertain. ISRG Expanding Beyond Surgery
• Positive Sentiment: Erste Group modestly raised its Intuitive Surgical earnings estimates to $8.94 per share for fiscal 2026 and $10.09 for fiscal 2027, above its prior forecasts and the broader current-year consensus of $8.87. Erste Group Earnings Estimate Changes

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.